Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis.
Biomarkers
/ blood
Cardiovascular Diseases
/ blood
Cause of Death
Dairy Products
/ adverse effects
Dietary Fats
/ administration & dosage
Fatty Acids
/ blood
Female
Humans
Incidence
Male
Middle Aged
Observational Studies as Topic
Prevalence
Protective Factors
Risk Assessment
Risk Factors
Sweden
/ epidemiology
Time Factors
Journal
PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
17
02
2021
accepted:
11
08
2021
entrez:
21
9
2021
pubmed:
22
9
2021
medline:
1
12
2021
Statut:
epublish
Résumé
We aimed to investigate the association of serum pentadecanoic acid (15:0), a biomarker of dairy fat intake, with incident cardiovascular disease (CVD) and all-cause mortality in a Swedish cohort study. We also systematically reviewed studies of the association of dairy fat biomarkers (circulating or adipose tissue levels of 15:0, heptadecanoic acid [17:0], and trans-palmitoleic acid [t16:1n-7]) with CVD outcomes or all-cause mortality. We measured 15:0 in serum cholesterol esters at baseline in 4,150 Swedish adults (51% female, median age 60.5 years). During a median follow-up of 16.6 years, 578 incident CVD events and 676 deaths were identified using Swedish registers. In multivariable-adjusted models, higher 15:0 was associated with lower incident CVD risk in a linear dose-response manner (hazard ratio 0.75 per interquintile range; 95% confidence interval 0.61, 0.93, P = 0.009) and nonlinearly with all-cause mortality (P for nonlinearity = 0.03), with a nadir of mortality risk around median 15:0. In meta-analyses including our Swedish cohort and 17 cohort, case-cohort, or nested case-control studies, higher 15:0 and 17:0 but not t16:1n-7 were inversely associated with total CVD, with the relative risk of highest versus lowest tertile being 0.88 (0.78, 0.99), 0.86 (0.79, 0.93), and 1.01 (0.91, 1.12), respectively. Dairy fat biomarkers were not associated with all-cause mortality in meta-analyses, although there were ≤3 studies for each biomarker. Study limitations include the inability of the biomarkers to distinguish different types of dairy foods and that most studies in the meta-analyses (including our novel cohort study) only assessed biomarkers at baseline, which may increase the risk of misclassification of exposure levels. In a meta-analysis of 18 observational studies including our new cohort study, higher levels of 15:0 and 17:0 were associated with lower CVD risk. Our findings support the need for clinical and experimental studies to elucidate the causality of these relationships and relevant biological mechanisms.
Sections du résumé
BACKGROUND
We aimed to investigate the association of serum pentadecanoic acid (15:0), a biomarker of dairy fat intake, with incident cardiovascular disease (CVD) and all-cause mortality in a Swedish cohort study. We also systematically reviewed studies of the association of dairy fat biomarkers (circulating or adipose tissue levels of 15:0, heptadecanoic acid [17:0], and trans-palmitoleic acid [t16:1n-7]) with CVD outcomes or all-cause mortality.
METHODS AND FINDINGS
We measured 15:0 in serum cholesterol esters at baseline in 4,150 Swedish adults (51% female, median age 60.5 years). During a median follow-up of 16.6 years, 578 incident CVD events and 676 deaths were identified using Swedish registers. In multivariable-adjusted models, higher 15:0 was associated with lower incident CVD risk in a linear dose-response manner (hazard ratio 0.75 per interquintile range; 95% confidence interval 0.61, 0.93, P = 0.009) and nonlinearly with all-cause mortality (P for nonlinearity = 0.03), with a nadir of mortality risk around median 15:0. In meta-analyses including our Swedish cohort and 17 cohort, case-cohort, or nested case-control studies, higher 15:0 and 17:0 but not t16:1n-7 were inversely associated with total CVD, with the relative risk of highest versus lowest tertile being 0.88 (0.78, 0.99), 0.86 (0.79, 0.93), and 1.01 (0.91, 1.12), respectively. Dairy fat biomarkers were not associated with all-cause mortality in meta-analyses, although there were ≤3 studies for each biomarker. Study limitations include the inability of the biomarkers to distinguish different types of dairy foods and that most studies in the meta-analyses (including our novel cohort study) only assessed biomarkers at baseline, which may increase the risk of misclassification of exposure levels.
CONCLUSIONS
In a meta-analysis of 18 observational studies including our new cohort study, higher levels of 15:0 and 17:0 were associated with lower CVD risk. Our findings support the need for clinical and experimental studies to elucidate the causality of these relationships and relevant biological mechanisms.
Identifiants
pubmed: 34547017
doi: 10.1371/journal.pmed.1003763
pii: PMEDICINE-D-21-00856
pmc: PMC8454979
doi:
Substances chimiques
14-pentadecenoic acid
0
Biomarkers
0
Dietary Fats
0
Fatty Acids
0
margaric acid
V987Y9OZ8L
Types de publication
Journal Article
Meta-Analysis
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1003763Subventions
Organisme : NCI NIH HHS
ID : T32 CA009001
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Eur J Nutr. 2018 Dec;57(8):2869-2876
pubmed: 29080977
Ann Intern Med. 2014 Mar 18;160(6):398-406
pubmed: 24723079
JAMA Cardiol. 2016 Oct 1;1(7):745-753
pubmed: 27541681
J Am Heart Assoc. 2014 Aug 13;3(4):
pubmed: 25122663
Circulation. 2015 Aug 18;132(7):586-94
pubmed: 26085453
Nutr J. 2009 May 21;8:21
pubmed: 19457271
Nutrients. 2020 Feb 23;12(2):
pubmed: 32102248
J Cardiovasc Thorac Res. 2017;9(1):1-11
pubmed: 28451082
PLoS Med. 2018 Oct 10;15(10):e1002670
pubmed: 30303968
PLoS Med. 2012;9(7):e1001255
pubmed: 22802735
Adv Nutr. 2012 May 01;3(3):266-85
pubmed: 22585901
Circ Res. 2018 Jan 19;122(2):369-384
pubmed: 29348256
Circulation. 2016 Apr 26;133(17):1645-54
pubmed: 27006479
Adv Nutr. 2019 Sep 1;10(5):924S-930S
pubmed: 31518411
PLoS One. 2018 May 8;13(5):e0196951
pubmed: 29738550
J Am Heart Assoc. 2013 Jul 18;2(4):e000092
pubmed: 23868191
BMC Med. 2021 Apr 15;19(1):92
pubmed: 33853582
Eur Heart J. 2016 Apr 1;37(13):1072-8
pubmed: 26396230
Sci Rep. 2021 Jan 14;11(1):1303
pubmed: 33446728
J Hum Nutr Diet. 2016 Jun;29(3):325-37
pubmed: 26264885
Nutrients. 2015 Sep 11;7(9):7749-63
pubmed: 26378576
PLoS One. 2016 Jun 29;11(6):e0158118
pubmed: 27355649
Epidemiology. 2012 Sep;23(5):770-1
pubmed: 22872120
Asia Pac J Clin Nutr. 2015;24(1):90-100
pubmed: 25740747
Am J Clin Nutr. 2011 Dec;94(6):1479-84
pubmed: 22030228
Crit Rev Food Sci Nutr. 2018 May 3;58(7):1122-1130
pubmed: 28001085
Foods. 2018 Mar 01;7(3):
pubmed: 29494487
Clin Sci (Lond). 1985 May;68(5):581-7
pubmed: 3919990
Circulation. 2010 Jun 1;121(21):2271-83
pubmed: 20479151
Am J Clin Nutr. 2013 Apr;97(4):698-705
pubmed: 23446892
Sci Rep. 2020 May 18;10(1):8161
pubmed: 32424181
Eur J Clin Nutr. 2006 Feb;60(2):236-44
pubmed: 16267503
BMJ. 2014 Oct 28;349:g6015
pubmed: 25352269
Adv Nutr. 2018 May 1;10(suppl_2):S164-S189
pubmed: 31089735
J Natl Cancer Inst. 2011 Jul 20;103(14):1086-92
pubmed: 21653922
Am J Clin Nutr. 2018 Sep 1;108(3):476-484
pubmed: 30007304
Am J Clin Nutr. 2017 Jun;105(6):1502-1511
pubmed: 28490510
Am J Clin Nutr. 2007 Oct;86(4):929-37
pubmed: 17921367
Am J Clin Nutr. 2010 Jul;92(1):194-202
pubmed: 20484449
Cerebrovasc Dis. 2013;36(1):38-46
pubmed: 23920478
Am J Clin Nutr. 2015 Jul;102(1):20-30
pubmed: 26016870
Adv Nutr. 2019 Nov 1;10(6):1066-1075
pubmed: 31124561
J Am Coll Cardiol. 2020 Aug 18;76(7):844-857
pubmed: 32562735
Stroke. 2013 Oct;44(10):2710-7
pubmed: 23899914
Br J Nutr. 2004 Apr;91(4):635-42
pubmed: 15035691
Nat Rev Cardiol. 2019 Oct;16(10):581-601
pubmed: 31097791
Lipids Health Dis. 2016 Feb 27;15:38
pubmed: 26920731
Eur J Epidemiol. 2017 Apr;32(4):269-287
pubmed: 28374228
Am J Clin Nutr. 2014 Dec;100(6):1437-47
pubmed: 25411278
Circulation. 2019 May 21;139(21):2422-2436
pubmed: 30971107
Clin Nutr. 2013 Oct;32(5):819-23
pubmed: 23473794
Eur J Nutr. 2019 Mar;58(2):529-539
pubmed: 29330661
Cochrane Database Syst Rev. 2020 May 19;5:CD011737
pubmed: 32428300
Am Heart J. 2008 Nov;156(5):965-74
pubmed: 19061714
J Nutr. 2001 Mar;131(3):828-33
pubmed: 11238766
Curr Opin Lipidol. 2017 Feb;28(1):46-51
pubmed: 27906713